Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis

about

Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis

Item

http://www.wikidata.org/entity/Q57330076

description

scientific article published on 01 June 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2017

@uk

name

Comparative efficacy and toler ...... th active rheumatoid arthritis

@en

Comparative efficacy and toler ...... th active rheumatoid arthritis

@nl

type

Item

label

Comparative efficacy and toler ...... th active rheumatoid arthritis

@en

Comparative efficacy and toler ...... th active rheumatoid arthritis

@nl

prefLabel

Comparative efficacy and toler ...... th active rheumatoid arthritis

@en

Comparative efficacy and toler ...... th active rheumatoid arthritis

@nl

P1476

Comparative efficacy and toler ...... f randomized controlled trials

@en

P2093

Y H Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial.

A Microsoft-Excel-based tool for running and critically appraising network meta-analyses--an overview and application of NetMetaXL

Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study.

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies.

The role of interleukin 6 in the pathophysiology of rheumatoid arthritis

Interleukin-6 as a key player in systemic inflammation and joint destruction.

P2888

s00393-017-0292-6

P304

421-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S00393-017-0292-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sang-Cheol Bae

P577

2018-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28324148

http://www.w3.org/2001/XMLSchema#string